Financhill
Sell
35

IGC Quote, Financials, Valuation and Earnings

Last price:
$0.33
Seasonality move :
23.08%
Day range:
$0.32 - $0.34
52-week range:
$0.27 - $0.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
19.13x
P/B ratio:
3.43x
Volume:
367.4K
Avg. volume:
413.2K
1-year change:
14.74%
Market cap:
$25.3M
Revenue:
$1.3M
EPS (TTM):
-$0.18

Earnings Data

Next earnings date for IGC
Feb 14
2025
Most recent earnings per share
-$0.02
Beat by $0.01
(Nov 12/2024)
Consensus Estimate
-$0.03
(Nov 12/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

IGC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 $295K -- -- -$0.03 --
02/14/2025 Q4 $204K -- -- -$0.03 --
11/12/2024 Q3 $291K $412K -$0.02 -$0.03 $0.01
08/07/2024 Q2 $455.5K $272K -$0.03 -$0.03 --
03/31/2024 Q1 $193K $295K -$0.04 -$0.04 --
02/14/2024 Q4 $448K $204K -$0.09 -$0.04 -$0.05
11/13/2023 Q3 -- -- -$0.05 -- --
06/30/2023 Q2 -- -- -$0.04 -- --
03/31/2023 Q1 -- -- -$0.08 -- --
12/31/2022 Q4 -- -- -$0.04 -- --
09/30/2022 Q3 -- -- -$0.05 -- --
08/05/2022 Q2 -- -- -$0.05 -- --
03/31/2022 Q1 -- -- -$0.12 -- --
02/10/2022 Q4 -- -- -$0.05 -- --
10/29/2021 Q3 -- -- -$0.09 -- --
08/11/2021 Q2 -- -- -$0.04 -- --
03/31/2021 Q1 -- -- -$0.07 -- --
02/12/2021 Q4 -- -- -$0.06 -- --
11/20/2020 Q3 -- -- -$0.04 -- --
08/19/2020 Q2 -- -- -$0.05 -- --
03/31/2020 Q1 -- -- -$0.08 -- --
02/12/2020 Q4 -- -- -$0.04 -- --
11/06/2019 Q3 -- -- -$0.03 -- --
08/09/2019 Q2 -- -- -- -- --
06/17/2019 Q1 -- -- -- -- --
02/12/2019 Q4 -- -- -- -- --
10/16/2018 Q3 -- -- -- -- --
08/02/2018 Q2 -- -- -- -- --
06/21/2018 Q1 -- -- -- -- --
02/20/2018 Q4 -- -- -- -- --
11/20/2017 Q3 -- -- -- -- --
06/30/2017 Q2 -- -- -- -- --
03/31/2017 Q1 -- -- -- -- --
12/31/2016 Q4 -- -- -- -- --
09/30/2016 Q3 -- -- -- -- --
08/17/2016 Q2 -- -- -- -- --
03/31/2016 Q1 -- -- -- -- --
12/31/2015 Q4 -- -- -- -- --
09/30/2015 Q3 -- -- -- -- --
06/30/2015 Q2 -- -- -- -- --
03/31/2015 Q1 -- -- -- -- --

IGC Pharma Earnings Questions

  • How Much did IGC Pharma Generate in Revenue Last Quarter?

    IGC Pharma reported $412K worth of top line sales in its most recent quarter.

  • Did IGC Pharma Beat Earnings Last Quarter?

    IGC Pharma announced earnings per share of -$0.02 which represents a beat of analyst forecast a -$0.03 per share.

  • Is IGC Pharma Profitable?

    IGC Pharma reported $198K that represents $0.00 per share over the last quarter.

  • What is the Analyst Consensus for IGC Pharma EPS Next Year?

    IGC Pharma's earnings are forecast to decrease from -$0.22 per share to -$0.11 per share next year representing a decrease of -40.91%.

  • When is IGC Pharma's Earnings Date?

    IGC Pharma's next earnings date is February 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Intuitive Machines on Sale?
Is Intuitive Machines on Sale?

In 2024, Intuitive Machines (NASDAQ:LUNR) hit an out-of-this-world milestone when…

Can Charles Schwab Stock Double?
Can Charles Schwab Stock Double?

Charles Schwab (NYSE:SCHW) needs no introduction as a goliath in…

Why Did Stanley Druckenmiller Buy Teva Stock?
Why Did Stanley Druckenmiller Buy Teva Stock?

Billionaire Stanley Druckenmiller has been shaking up his portfolio lately,…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 38x

Buy
54
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
37
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 99x

Alerts

Buy
59
AKRO alert for Jan 28

Akero Therapeutics [AKRO] is down 0.39% over the past day.

Sell
23
NBIS alert for Jan 28

Nebius Group NV [NBIS] is up 15.34% over the past day.

Sell
36
CRDO alert for Jan 28

Credo Technology Group Holding [CRDO] is up 4.66% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock